Shemin Lu
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Cancer-related molecular mechanisms research 24
- MicroRNA in disease regulation 21
- Rheumatology 24
- Osteoarthritis Treatment and Mechanisms 12
- Co-authors
- Manman GengXiaowei LiRikard HolmdahlCongshan JiangLiesu MengPeter OlofssonJens HolmbergWenhua Zhu
- Journals
- Journal of Pharmaceutical Analysis (7 papers)Molecular and Cellular Endocrinology (6 papers)Bioorganic & Medicinal Chemistry (6 papers)Frontiers in Immunology (5 papers)The Journal of Immunology (4 papers)
- Partner nations
- ChinaSwedenUnited States
In The Last Decade
Shemin Lu
163 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Cancer Research 798
- Infectious Diseases 938
- Immunology 934
- Rheumatology 537
- Molecular Biology 1.9k
Countries citing papers authored by Shemin Lu
This map shows the geographic impact of Shemin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shemin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shemin Lu more than expected).
Fields of papers citing papers by Shemin Lu
This network shows the impact of papers produced by Shemin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shemin Lu. The network helps show where Shemin Lu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shemin Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 82 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 11 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 12 | |
| 9 | 2022 | 2 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 13 | |
| 12 | 2020 | 22 | |
| 13 | 2020 | 31 | |
| 14 | 2019 | 6 | |
| 15 | 2019 | 24 | |
| 16 | 2019 | 11 | |
| 17 | 2018 | 9 | |
| 18 | 2018 | 13 | |
| 19 | 2017 | 44 | |
| 20 | 2015 | 22 |
About Shemin Lu
Shemin Lu is a scholar working on Cancer Research, Rheumatology, Immunology, Immunology and Allergy and Molecular Biology, having authored 164 papers that have together received 5.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (24 papers), MicroRNA in disease regulation (21 papers), Selenium in Biological Systems (14 papers), Cancer-related gene regulation (12 papers), Osteoarthritis Treatment and Mechanisms (12 papers), Circular RNAs in diseases (11 papers), Cytokine Signaling Pathways and Interactions (10 papers) and Immune Response and Inflammation (9 papers). The work is most often cited by research in Cancer Research (798 citations), Infectious Diseases (938 citations), Immunology (934 citations), Rheumatology (537 citations) and Molecular Biology (1.9k citations). Shemin Lu has collaborated with scholars based in China, Sweden and United States. Frequent co-authors include Manman Geng, Xiaowei Li, Rikard Holmdahl, Congshan Jiang, Liesu Meng, Peter Olofsson, Jens Holmberg, Wenhua Zhu, Qingzhu Sun and Jian Sun. Their work appears in journals such as Journal of Pharmaceutical Analysis, Molecular and Cellular Endocrinology, Bioorganic & Medicinal Chemistry, Frontiers in Immunology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.